CDR-H3/C2 is the complementarity-determining region peptide derived from the third heavy-chain domain (CDR/H3) of the mouse monoclonal antibody F58. It can act as a miniantibody and inhibit HIV-1 replication as well as syncytium formation by infected cells. M. Levi et al., Proc. Natl. Acad. Sci. USA, 90, 4374 (1993).
M.W.: 2130.26
